Bright NIR-II fluorescence lipid membrane probes for labelling of biomimetic nanovesicles with image-guided targeted NIR-II mild photothermal-immunotherapy of orthotopic glioblastoma.
Cell-derived nanovesicles possess the capacity to cross the blood-brain barrier (BBB) and modulate the immunosuppressive tumor microenvironment (TME); however, the lack of efficient labelling probes limits their application in tracing biodistribution and achieving synergistic glioblastoma (GBM) theranostics. Herein, we...